Richard C. Woodman
Director/Board Member at H3 Biomedicine, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ping Zhu | M | - |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | 12 years |
| Mary Shoemaker | F | 63 | 4 years | |
| Takashi Owa | M | 60 |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | - |
| William Brody | M | 80 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 15 years |
| Hans Jörg Reinhardt | M | 68 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 11 years |
| Yasunobu Kai | M | 62 |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | - |
| Jennifer Taubert | F | 60 | 19 years | |
| Alexander Scott | M | - |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | - |
| Brian Liau | M | - |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | - |
| Elizabeth Forminard | F | 53 | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ramesh Kumar | M | 68 | 21 years | |
| Michael Hoffman | M | 73 | 18 years | |
| James T. Lenehan | M | 75 | 28 years | |
| Michael Johns | M | 82 | 9 years | |
| Charles O. Prince | M | 74 | 17 years | |
| Joseph Truitt | M | 59 | 4 years | |
| Hemanshu Shah | M | 63 | 1 years | |
| E. Premkumar Reddy | M | 80 | 22 years | |
| David Satcher | M | 83 | - | |
| Paulus Stoffels | M | 62 | 19 years | |
| Evan Norton | M | 49 | 3 years | |
| Rosemary Crane | F | 64 | 6 years | |
| Carla Sivak | F | - | 4 years | |
| Christopher DelOrefice | M | 52 | 8 years | |
| Lisa Romanko | F | - | 19 years | |
| Joanne Waldstreicher | M | 63 | 21 years | |
| Mary Coleman | M | 80 | 13 years | |
| Christophe Soulier | M | - | 5 years | |
| Susan L. Lindquist | M | 74 | - | |
| Ralph S. Larsen | M | 85 | 19 years | |
| Henry B. Schacht | M | 89 | 8 years | |
| Ravi Kiron | M | 64 | 3 years | |
| Vanessa Broadhurst | F | 55 | 16 years | |
| Tracy Campbell Accardi | F | 64 | 4 years | |
| Karen Borg | F | - | - | |
| David Abraham | M | 58 | 2 years | |
| Suresh Kumar | M | 69 | 5 years | |
| Suzanne Blaug | F | 66 | - | |
| Stefan Schwabe | M | 72 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 2 years |
| Mohan Nathan | M | - | 3 years | |
| David Duerst | M | - | 11 years | |
| Max Kahn | M | - | 5 years | |
| Robert W. Boyce | M | - | 7 years | |
| Sung-Jin Lee | M | 54 | - | |
| Jules Müsing | M | 76 | 7 years | |
| Jabulani Mahange | M | 63 | 4 years | |
| Janice M. Smiell | M | - | 9 years | |
| Alan F. Joslyn | M | 65 | 9 years | |
| Geert Cauwenbergh | M | 70 | 8 years | |
| Yves Decadt | M | 57 | 5 years | |
| Natasha Kehimkar | F | - | 2 years | |
| Matt Roberts | M | 50 | - | |
| Hua Gong | M | 57 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 7 years |
| Suneel Gupta | M | 66 | 6 years | |
| David Pass | M | 56 | 6 years | |
| Larry G. Pickering | M | 81 | - | |
| Joy L. Frestedt | M | - | 4 years | |
| Sarah Glickman | F | 54 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 1 years |
| Michael P. Cooke | M | 62 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 17 years |
| Patrick Burnett | M | 52 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 5 years |
| Denice Torres | F | 64 | 12 years | |
| Ralph Kern | M | 67 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | - |
| Christi L. Shaw | F | 57 | - | |
| Raymond C. Jordan | M | 70 | 9 years | |
| LaVerne Council | F | 62 | 5 years | |
| M. Judah Folkman | M | - | 7 years | |
| Craig Fraser | M | 59 | 4 years | |
| John Orwin | M | 62 | 4 years | |
| Ahmed Hamdy | M | 59 | 2 years | |
| Robert E. Kirby | M | 67 | 2 years | |
| Chris Tompson | M | - | - | |
| Philippe Schaison | M | 62 | 6 years | |
| Steven Reinemund | M | 75 | 5 years | |
| Louise Mehrotra | F | - | 11 years | |
| Mark R. Straley | M | 63 | - | |
| Garry Neil | M | 70 | 10 years | |
| Bridgette Heller | F | 62 | 5 years | |
| Joseph Squicciarino | M | 67 | 1 years | |
| Tony Vernon | M | 68 | 23 years | |
| George F. Schreiner | M | 74 | 3 years | |
| Gerard N. Burrow | M | - | 12 years | |
| Francois A. Menard | M | 64 | 8 years | |
| Ronald van der Geest | M | - | - | |
| Douglas K. Chia | M | - | - | |
| Kaye Foster-Cheek | F | 64 | 7 years | |
| Philip M. Croxford | M | 63 | 3 years | |
| Elizabeth Cermak | F | 66 | - | |
| Kristine Peterson | F | 64 | 5 years | |
| Koen Hasaers | M | 59 | 5 years | |
| Peter Fasolo | M | 61 | 3 years | |
| Anil Kapur | M | 54 | 11 years | |
| Glen A. Kashuba | M | 61 | 7 years | |
| Dariusz Robert Gorka | M | 59 | 1 years | |
| Sean Cao | M | - | 3 years | |
| Angela Ogden | M | - | 3 years | |
| Benito Cachinero-Sánchez | M | 65 | 3 years | |
| John Tagliamonte | M | 57 | 3 years | |
| David Shamis | M | - | 2 years | |
| David Mullarkey | M | 57 | 5 years | |
| Sally A. Berry | M | - | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard C. Woodman
- Personal Network
